Skip to main content

People in the News: Paul Grossman, Christine Meda

Premium

Former Life Technologies executive Paul Grossman has joined Telegraph Hill Partners as a venture partner. Grossman previously was head of global strategy and corporate development at Life Tech, and he also held the same position at Invitrogen. Before he joined Invitrogen, Grossman held various leadership roles at Applied Biosystems, including as a research scientist and patent attorney, VP of intellectual property, and VP of strategy and business development.


IncellDx has hired healthcare industry veteran Christine Meda as its chief business officer. In this role, she will be in charge of partnering with drug developers to drive adoption of IncellDx's Cellular Multiplexing technology, which gauges proteomic and genomic markers in a single assay.

Previously, Meda was president of Response Genetics and VP of women's health at Roche Molecular Diagnostics, and director of scientific affairs at Schering AG.

The Scan

Call to Look Again

More than a dozen researchers penned a letter in Science saying a previous investigation into the origin of SARS-CoV-2 did not give theories equal consideration.

Not Always Trusted

In a new poll, slightly more than half of US adults have a great deal or quite a lot of trust in the Centers for Disease Control and Prevention, the Hill reports.

Identified Decades Later

A genetic genealogy approach has identified "Christy Crystal Creek," the New York Times reports.

Science Papers Report on Splicing Enhancer, Point of Care Test for Sexual Transmitted Disease

In Science this week: a novel RNA structural element that acts as a splicing enhancer, and more.